NPI: 1326008756 · WHEATON, MD 20902 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/28/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 03/28/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,750 | $35K |
| 2019 | 9,037 | $55K |
| 2020 | 4,267 | $60K |
| 2021 | 408 | $7K |
| 2022 | 464 | $12K |
| 2023 | 373 | $21K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 4,141 | 528 | $126K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,559 | 652 | $50K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,456 | 505 | $6K |
| 83970 | 405 | 371 | $3K | |
| J1756 | Injection, iron sucrose, 1 mg | 984 | 288 | $2K |
| A4657 | Syringe, with or without needle, each | 1,547 | 731 | $2K |
| 83540 | 359 | 337 | $0.00 | |
| 85048 | 511 | 478 | $0.00 | |
| 85041 | 507 | 475 | $0.00 | |
| 82108 | 43 | 41 | $0.00 | |
| 83550 | 360 | 337 | $0.00 | |
| 82728 | 314 | 291 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 82 | 81 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 31 | 29 | $0.00 |